Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,91 USD | +4,72% | +2,06% | +22,48% |
06/03 | CARA THERAPEUTICS, INC. : Canaccord Genuity nog altijd een koopadvies | ZM |
04/03 | Transcript : Cara Therapeutics, Inc., Q4 2023 Earnings Call, Mar 04, 2024 |
Omzet 2024 * | 5,59 mln. 5,18 mln. | Omzet 2025 * | 3,67 mln. 3,4 mln. | Marktkapitalisatie | 49,74 mln. 46,11 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -64 mln. -59,34 mln. | Nettowinst (verlies) 2025 * | -81 mln. -75,1 mln. | EV/omzet 2024 * | 7,04 x |
Nettoliquiditeiten 2024 * | 10,4 mln. 9,64 mln. | Nettoschuld 2025 * | 29,1 mln. 26,98 mln. | EV/omzet 2025 * | 21,5 x |
K/w-verhouding 2024 * |
-0,78
x | K/w-verhouding 2025 * |
-0,81
x | Werknemers | 55 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 85,41% |
Recentste transcriptie over Cara Therapeutics, Inc.
1 dag | +4,72% | ||
1 week | +2,06% | ||
Lopende maand | +7,03% | ||
1 maand | +2,25% | ||
3 maanden | +18,61% | ||
6 maanden | -46,15% | ||
Lopend jaar | +22,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 06-08-18 | |
Ryan Maynard
DFI | Director of Finance/CFO | 54 | 12-09-22 |
Joana Goncalves
CTO | Chief Tech/Sci/R&D Officer | 50 | 23-10-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Martin Vogelbaum
CHM | Chairman | 60 | 01-07-10 |
Jeffrey Ives
BRD | Director/Board Member | 73 | 16-07-14 |
Helen Boudreau
BRD | Director/Board Member | 58 | 02-08-23 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
11.20% | 29 M€ | +35,13% | - | |
1.29% | 13 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 0,91 | +4,72% | 637 279 |
27-03-24 | 0,869 | +19,01% | 569 385 |
26-03-24 | 0,7302 | -10,94% | 711 831 |
25-03-24 | 0,8199 | -7,18% | 470 713 |
22-03-24 | 0,8833 | -0,93% | 204 803 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,48% | 49,74 mln. | |
+0,44% | 90,78 mld. | |
+9,61% | 43,96 mld. | |
-16,67% | 31,34 mld. | |
+44,99% | 23,45 mld. | |
-9,42% | 16,48 mld. | |
-25,92% | 15,03 mld. | |
-9,27% | 12,79 mld. | |
-7,57% | 12,19 mld. | |
+0,07% | 8,5 mld. |